{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:54:32Z","timestamp":1778590472952,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.clinthera.2011.08.006","type":"journal-article","created":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T01:45:39Z","timestamp":1315619139000},"page":"1204-1213.e3","source":"Crossref","is-referenced-by-count":37,"title":["Effects of Prolonged-Release Torasemide Versus Furosemide on Myocardial Fibrosis in Hypertensive Patients with Chronic Heart Failure: A Randomized, Blinded\u2013End Point, Active-Controlled Study"],"prefix":"10.1016","volume":"33","clinical-trial-number":[{"clinical-trial-number":"nct00409942","registry":"10.18810\/clinical-trials-gov"}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.08.006_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0733-8651(05)70154-5","article-title":"Connective tissue and the heart","volume":"18","author":"Burlew","year":"2000","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.clinthera.2011.08.006_bib2","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejcts.2006.07.006","article-title":"The relationship between myocardial extracellular matrix remodeling and ventricular function","volume":"30","author":"Brower","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.clinthera.2011.08.006_bib3","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.CIR.0000140973.60992.9A","article-title":"Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis","volume":"110","author":"Querejeta","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2011.08.006_bib4","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/01.hjh.0000173780.67308.f1","article-title":"The use of collagen-derived serum peptides for the clinical assessment of hypertensive heart disease","volume":"23","author":"Lopez","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.clinthera.2011.08.006_bib5","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/01.CIR.101.14.1729","article-title":"Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease","volume":"101","author":"Querejeta","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2011.08.006_bib6","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1161\/CIRCULATIONAHA.109.912774","article-title":"Circulating biomarkers of collagen metabolism in cardiac diseases","volume":"121","author":"Lopez","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2011.08.006_bib7","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2003.12.052","article-title":"Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure","volume":"43","author":"Lopez","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2011.08.006_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bcp.2007.09.026","article-title":"Comparative effects of torasemide and furosemide in rats with heart failure","volume":"75","author":"Veeraveedu","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clinthera.2011.08.006_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1527-3466.2008.00046.x","article-title":"Clinical effects of torasemide prolonged release in mild-to-moderate hypertension: a randomized noninferiority trial versus torasemide immediate release","volume":"26","author":"Roca-Cusachs","year":"2008","journal-title":"Cardiovas Ther"},{"key":"10.1016\/j.clinthera.2011.08.006_bib10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1586\/erc.09.74","article-title":"TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure","volume":"7","author":"D\u00edez","year":"2009","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.clinthera.2011.08.006_bib11","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology","volume":"28","author":"Paulus","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2011.08.006_bib12","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1161\/HYPERTENSIONAHA.109.149112","article-title":"Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction","volume":"55","author":"Gonz\u00e1lez","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.clinthera.2011.08.006_bib13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0002-8703(92)90986-6","article-title":"Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan","volume":"124","author":"Rector","year":"1992","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinthera.2011.08.006_bib14","series-title":"Missing Data in Clinical Studies","author":"Molenberghs","year":"2007"},{"key":"10.1016\/j.clinthera.2011.08.006_bib15","series-title":"Statistical Issues in Drug Development","article-title":"Baseline and covariate information","author":"Senn","year":"2007"},{"key":"10.1016\/j.clinthera.2011.08.006_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1440-1681.2008.05089.x","article-title":"A bioavailability\/bioequivalence and pharmacokinetic study of two oral doses of torasemide (5 and 10 mg): prolonged-release versus the conventional formulation","volume":"36","author":"Barbanoj","year":"2009","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811005443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811005443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T05:56:23Z","timestamp":1543557383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811005443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0149291811005443"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.08.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}